These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34834220)

  • 1. Transdermal Delivery of Macromolecules Using Two-in-One Nanocomposite Device for Skin Electroporation.
    Simon J; Jouanmiqueou B; Rols MP; Flahaut E; Golzio M
    Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin electroporation for transdermal drug delivery: Electrical measurements, numerical model and molecule delivery.
    Kougkolos G; Laudebat L; Dinculescu S; Simon J; Golzio M; Valdez-Nava Z; Flahaut E
    J Control Release; 2024 Mar; 367():235-247. PubMed ID: 38244842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Hydrogel/Carbon-Nanotube Needle-Free Device for Electrostimulated Skin Drug Delivery.
    Guillet JF; Flahaut E; Golzio M
    Chemphyschem; 2017 Oct; 18(19):2715-2723. PubMed ID: 28796918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of macromolecules using skin electroporation.
    Lombry C; Dujardin N; Préat V
    Pharm Res; 2000 Jan; 17(1):32-7. PubMed ID: 10714605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of voltage gated transdermal drug delivery platform to impose synergistic enhancement in skin permeation using electroporation and gold nanoparticle.
    Anirudhan TS; Nair SS
    Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():437-446. PubMed ID: 31147014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery.
    Blagus T; Markelc B; Cemazar M; Kosjek T; Preat V; Miklavcic D; Sersa G
    J Control Release; 2013 Dec; 172(3):862-71. PubMed ID: 24113487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal delivery of nalbuphine and its prodrugs by electroporation.
    Sung KC; Fang JY; Wang JJ; Hu OY
    Eur J Pharm Sci; 2003 Jan; 18(1):63-70. PubMed ID: 12554074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal drug delivery by in-skin electroporation using a microneedle array.
    Yan K; Todo H; Sugibayashi K
    Int J Pharm; 2010 Sep; 397(1-2):77-83. PubMed ID: 20619329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroporation as an efficient physical enhancer for skin drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Revilla-Vázquez AL
    J Clin Pharmacol; 2009 Nov; 49(11):1262-83. PubMed ID: 19717723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule.
    Zewert TE; Pliquett UF; Vanbever R; Langer R; Weaver JC
    Bioelectrochem Bioenerg; 1999 Oct; 49(1):11-20. PubMed ID: 10619443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroporation: an avenue for transdermal drug delivery.
    Charoo NA; Rahman Z; Repka MA; Murthy SN
    Curr Drug Deliv; 2010 Apr; 7(2):125-36. PubMed ID: 20158490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macromolecules as novel transdermal transport enhancers for skin electroporation.
    Vanbever R; Prausnitz MR; Préat V
    Pharm Res; 1997 May; 14(5):638-44. PubMed ID: 9165536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practical assessment of transdermal drug delivery by skin electroporation.
    Prausnitz MR
    Adv Drug Deliv Rev; 1999 Jan; 35(1):61-76. PubMed ID: 10837689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of optimized electroporation enhances the transdermal efficiency of sinomenine hydrochloride for treating arthritis in vitro and in clinic.
    Feng S; Zhu L; Huang Z; Wang H; Li H; Zhou H; Lu L; Wang Y; Liu Z; Liu L
    Drug Des Devel Ther; 2017; 11():1737-1752. PubMed ID: 28670109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules.
    Li YZ; Quan YS; Zang L; Jin MN; Kamiyama F; Katsumi H; Tsutsumi S; Yamamoto A
    J Pharm Pharmacol; 2009 Aug; 61(8):1005-12. PubMed ID: 19703343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
    Zorec B; Zupančič Š; Kristl J; Pavšelj N
    Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin electroporation causes molecular transport across the stratum corneum through localized transport regions.
    Chen T; Langer R; Weaver JC
    J Investig Dermatol Symp Proc; 1998 Aug; 3(2):159-65. PubMed ID: 9734832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo efficacy and safety of skin electroporation.
    Vanbever R; Préat V
    Adv Drug Deliv Rev; 1999 Jan; 35(1):77-88. PubMed ID: 10837690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal drug delivery using electroporation. II. Factors influencing skin reversibility in electroporative delivery of terazosin hydrochloride in hairless rats.
    Sharma A; Kara M; Smith FR; Krishnan TR
    J Pharm Sci; 2000 Apr; 89(4):536-44. PubMed ID: 10737915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A propagating heat wave model of skin electroporation.
    Pliquett U; Gusbeth Ch; Nuccitelli R
    J Theor Biol; 2008 Mar; 251(2):195-201. PubMed ID: 18190931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.